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Abstract
Aspergilli section Flavi, originally isolated from air samples collected from inhabited apartments (AP), unoccupied basements
(BS), and processing facilities of a grain mill (GM), were analyzed for their potential to produce aflatoxin B1 (AFB1) on solid
media. The isolates were further characterized with regard to their cytotoxic, genotoxic, and pro-inflammatory properties in vitro.
Aspergilli were identified based on partial calmodulin (CaM) gene sequencing; the producing capacities of isolates were analyzed
by HPLC/FLD and confirmed by genes in biosynthesis (aflR, norA, omtA). In the grain mill, the Aspergilli section Flavi (up to
1.3 × 106 cfu/m3) dominated by AFB1-producing Aspergillus flavus (71%, 4.5–5254 ng/ml) which showed a serious health risk
for workers. Living environments were not relevant sources of exposure. After 24 h, AFB1 (1–100 μmol/l) reduced cell viability
(MTT test) in both A549 cells and THP-1 macrophage-like cells without reaching IC50. In A549 cells, the extract of the AFB1-
producing A. flavus significantly decreased cell viability but not below 50%. THP-1 macrophage-like cells were more sensitive to
both extracts, but IC50 was obtained only for the AFB1-producing strain (0.37 mg/ml; AFB1 2.78 μmol/l). AFB1 (1 and 10 μmol/
l) induced significant DNA damage (tail intensity, alkaline comet assay) in A549 cells in contrast to Aspergilli extracts. AFB1
elevated IL-6 and IL-8, while Aspergilli extracts increased IL-1β, TNF-α, and IL-17 release in THP-1 macrophages (ELISA).
Chronic exposure to AFB1 and/or other metabolites in airborne A. flavus from occupational environments may stimulate
epithelial damage of airways accompanied by lowered macrophage viability.
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Introduction
The Aspergillus section Flavi comprises several species wide-
ly distributed in the environment. These species can be sepa-
rated into two groups based on their economic importance and
impact on human and animal health. The first group includes
the non-producing aflatoxin species Aspergillus oryzae,
Aspergillus sojae, and Aspergillus tamarii used in oriental
food fermentation (Campbell-Platt 1994). Genetically modi-
fied A. oryzae strains are used for the production of enzymes,
including lactase, pectin esterase, lipase, protease, and
xylanase (Pariza and Johnson 2001). The second group in-
cludes aflatoxin-producing species Aspergillus flavus,
Aspergillus parasiticus, and Aspergillus nomius, which con-
taminate and damage various pre-harvested and stored agri-
cultural products (Perrone et al. 2014). In the past decade, the
production of aflatoxins was also reported in newly described
species Aspergillus arachidicola, Aspergillus bombycis,
Aspergillus minisclerotigenes, Aspergillus parvisclerotigenus,
Aspergillus pseudocaelatus, Aspergillus pseudonomius,
Aspergillus pseudotamari, Aspergillus togoensis, Aspergillus
mottae, Aspergillus sergii, and Aspergillus transmontanensis
(Varga et al. 2011; Soares et al. 2012).
Aflatoxins are known hepatotoxic mycotoxins with carci-
nogenic, genotoxic, and teratogenic properties in both humans
and animals (Bennett et al. 2003). Among these mycotoxins,
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aflatoxin B1 (AFB1) is the most toxic as well as the most
frequently occurring aflatoxin in agricultural products (Varga
et al. 2011).
In general, aflatoxins are principally produced by A. flavus
and A. parasiticus; A. flavus mainly produces AFB1 and
AFB2, while most A. parasiticus isolates produce AFG1 and
AFG2 in addition to AFB1 and AFB2. However, A. flavus is
considered more invasive and out-competes A. parasiticus
when both species are present in soil (Perrone et al. 2014).
Aflatoxigenic strains of A. flavus are most widespread in trop-
ical and subtropical areas. However, in recent years, a more
frequent occurrence of aflatoxin producers has been detected
in temperate-climate regions, associated with current climate
change. Air humidity changes (abundant rain, droughts), in-
crease in temperature, and increased CO2 concentration direct-
ly affect the expression of regulatory (aflR) and structural
genes (aflD) involved in the biosynthesis of AFB1 and, thus,
correlate with its biosynthesis (Paterson and Lima 2010;
Medina et al. 2014).
Next to A. fumigatus, A. flavus is the second most frequent
cause of invasive and non-invasive aspergillosis in humans; it
may also cause sinusitis, cutaneous and wound aspergillosis,
as well as otitis and keratitis (Hedayati et al. 2007;
Manikandan et al. 2013).
Taking into account the aflatoxigenic ability of the listed
Aspergilli section Flavi, particularly A. flavus, as well as its
role in the etiology of several diseases in humans, an accurate
identification of the species would provide fundamental infor-
mation concerning their aflatoxigenic and pathogenic proper-
ties (Godet and Munaut 2010). Several molecular genetic
techniques have been developed to distinguish the
Aspergillus species in the section Flavi; Varga et al. (2011)
proposed a polyphasic approach, including morphological
characters, extrolite data, and partial calmodulin (CaM), β-
tubulin (BenA), and ITS sequences as well as the presence of
genes involved in aflatoxin biosynthesis.
Since the discovery of aflatoxins, the hepatotoxic action of
AFB1 has beenmainly studied in various experimental models
through AFB1-contaminated food consumption (Bennett et al.
2003). However, a link between AFB1 inhalation in an indus-
trial setting and liver or lung cancer incidence and mortality
has been suggested by several investigations (Olsen et al.
1988; Viegas et al. 2012). Taking into account the lack of data
on human exposure to fungal burden in urban homes and
occupational settings in our country, recently, we conducted
a year-round investigation of airborne fungi in living (apart-
ments, basements) and occupational (grain mill) indoor envi-
ronments in Croatia with special attention to Aspergillus sec-
tions Flavi, Nigri, and Versicolores due to their known patho-
genic and/or mycotoxin-producing properties (Jakšić Despot
and Šegvić Klarić 2014,b). Based on morphological methods,
Aspergilli sections Flavi and Nigri were recovered in the
highest frequencies (50–100% and 15–55%, respectively)
from samples taken in the grain mill, while Aspergilli section
Versicoloreswas more abundant in apartments and basements
(10–65%) (Jakšić Despot and Šegvić Klarić 2014,b). Before
appropriate molecular identification methods for species
assigned to these sections, indoor air isolates were usually
reported as A. flavus, A. niger, or A. versicolor (Samson
et al. 2014). As we previously noted, accurate identification
of the Aspergillus species is fundamental with regard to their
toxigenic and/or pathogenic properties (Godet and Munaut
2010). Thus, herein, we described the species diversity of
Aspergillus sections Nigri (Jakšić et al. 2018) and
Versicolores (Jakšić Despot et al. 2016) using calmodulin
sequence-based methods, their ability to produce fumonisin
B2 and sterigmatocystin, respectively, and to explore toxic
potential of Aspergilli extracts in comparison with these my-
cotoxins alone. To further extend knowledge on Aspergillus
section Flavi biology and toxicology, the present study aimed
to explore the species diversity of isolated strains using a
polyphasic approach (morphological methods, CaM se-
quence, and presence of genes taking part in aflatoxin biosyn-
thesis) and confirm aflatoxin-producing abilities in Aspergilli
extracts by HPLC/FLD.
Some studies showed that AFB1 alone induces several tox-
ic events in human airways, including damage of airway epi-
thelial cells, decrease of the ciliary beat frequency (Lee et al.
2016), DNA damage due to formation of exo-AFB1-8,9-ep-
oxide by human lung microsomes (Kelly et al. 1997) as well
as takes a part in inflammation (Lee et al. 2016; Luongo et al.
2014). However, the effects of inhaled aflatoxin-producing
fungi on the airway epithelium have not been well-
characterized so far.
As A. flavus was among the most abundant species in the
grain mill, it was justified to explore the cytotoxic, genotoxic,
and immunomodulatory properties of AFB1-producing and
AFB1-non-producing A. flavus extracts in contrast to AFB1
alone in order to clarify whether particular toxic properties
of Aspergilli could be attributed to AFB1. This was carried
out using human lung adenocarcinoma A549 cells and mac-
rophages derived from human leukemic monocyte THP-1
cells as experimental models.
Materials and methods
Chemicals and media
Methanol, acetonitrile, methylene chloride, ethyl acetate, and
n-hexane for sample preparation and eluents were purchased
from VWR (Debrecen, Hungary). Formic acid, trifluoroacetic
acid, and aflatoxin B1 standard were obtained from Sigma-
Aldrich (Budapest, Hungary). Deionized water for both sam-
ple preparation and high-performance liquid chromatography
(HPLC) runs was produced by Merck Millipore Milli-Q
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Gradient A10 water purification equipment (Budapest,
Hungary). Dichloran 18% glycerol agar (DG-18), Czapek
Yeast Agar (CYA), and Malt Extract Agar (MEA) were pur-
chased from Oxoid (Hampshire, UK). Media for cell culture
maintenance, including RPMI 1640, fetal bovine serum
(FBS), trypsin-EDTA, phosphate-buffered saline (PBS; Ca2+
and Mg2+ free), penicillin, and streptomycin were from Lonza
(Basel, Switzerland). MTT reagent [3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide], phorbol 12-myristate
13-acetate (PMA) ethidium bromide, acridine orange, normal
melting point (NMP) agarose, low melting point (LMP) aga-
rose, Triton X-100, Tris buffer, and dimethyl sulfoxide
(DMSO) were purchased from Sigma-Aldrich (Deisenhofen,
Germany). Dimethyl sulfoxide (DMSO) ethanol HCl, NaCl,
Na2EDTA, and NaOH were from Kemika (Zagreb, Croatia).
Sampling areas
The samples of airborne fungi were collected over a one-year
period (2012) in two-month intervals at the processing facili-
ties of a grain mill (GM) situated near Zagreb, Croatia, as well
as in residential locations in the city which included two
inhabited apartments (AP) and two unoccupied basements
(BS) as well as outdoor air (ODA) as described in detail in
Jakšić Despot and Šegvić Klarić (2014,b). In each period of
sampling in GM, twenty samples were collected during mill-
ing operations at the site of grain/flour exchange, site of flour
storage, site of sieving, and site of milling. In each AP (ap-
proximately 70 m2), samples were taken at five locations,
including the kitchen, dining room, living room, bedroom,
and bathroom, in duplicate. BSs were located in the same
buildings as the AP, and residents used these spaces to store
various items (e.g., wooden, metal, plastic, or glass materials).
In each BS, samples were taken at five locations in duplicate.
Samples of outdoor air were taken in proximity to indoor
locations, and, during each sampling period, ten ODA sam-
ples were collected.
The sampling approach included collecting 20 indoor sam-
ples and 10 outdoor samples per each location and at a given
time point. Altogether, 420 individual samples were taken.
Sample collection
Airborne fungi were sampled using an Airsampler Mas-100
Eco (Merck, Berlin, Germany) with 400 holes (hole to agar
impactor, impaction velocity 10.8 m/s, and airflow rate 100 l/
min) and DG-18 agar plates (Samson et al. 2010). Because of
the high contamination level, a volume of 10 l was chosen for
sampling in the GM, while a volume of 50 l was applied at the
other sampling locations. The plates were incubated at 25 °C
± 0.2 °C in the dark for five days, after which the developed
fungal colonies were counted, and results were expressed as
colony-forming units per cubic meter (cfu/m3). Aspergilli
were isolated on CYA and MEA agar plates (Samson et al.
2010). Isolates assigned to the Aspergillus section Flavi were
purified and cultivated on CYA and MEA plates at 25 °C in
the dark for seven days. Morphological identifications were
carried out according to literature (Samson et al. 2010).
Determination of Aspergilli section Flavi genotypes
Isolation of genomic DNA frommycelia grown in liquid YPD
medium (1% Bacto yeast extract, 1% Bacto peptone, 1% D-
glucose) for five days was performed by Masterpure™ yeast
DNA purification kit (Epicentre Biotechnologies, Madison,
WI, USA) according to the manufacturer’s instructions. The
isolated DNAwas diluted to < 1.000 ng and used as template
DNA in PCR reactions. A fragment of the calmodulin gene
(CaM), part of the transcriptional regulator of aflatoxin bio-
synthesis (aflR), norsolorinic acid reductase (norA or aflE),
and O-methyltransferase gene (omtA, aflP) (Yu et al. 2004)
were amplified using the primers specified in Table 1. Each
PCR reaction mixture (20 μl) contained 0.2 mmol/l deoxyri-
bonucleotide triphosphate (dNTP), 0.2 μmol of primers, 1 U
DreamTaq DNA Polymerase (Thermo Scientific, Madison,
WI, USA) with the respective buffer (with 1.5 mmol/l
MgCl2) (Thermo Scientific, Madison, WI, USA), nuclease-
free water, and template DNA. Amplifications were per-
formed using a Thermocycler T-100 (BioRad, Budapest,
Hungary). The PCR cycling protocol consisted of 35 cycles,
including an initial denaturation at 95 °C for 2 min in the first
and 20 s in the following runs, annealing temperature as spec-
ified in Table 1 for 20 s, elongation at 72 °C for 40 s, and 2min
for the final elongation. The amplification products were an-
alyzed by electrophoresis on 2% agarose gels using fluores-
cent dye GR Green (Excellgen, Budapest, Hungary), and the
banding patterns were visualised under ultraviolet light
(254 nm). In case of PCR products assigned to aflR, norA,
and omtA, the bands were scored as either present or absent for
eachA. flavus isolate. PartialCaM sequences were determined
at the LGC Genomics GmbH (Berlin, Germany). Sequence
analysis was performed by nucleotide–nucleotide BLAST
similarity search at the website of the National Center for
Biotechnology Information (http://www.ncbi.nlm. nih.gov/
BLAST), and sequences were, also, compared with our own
sequence database. Species identification was determined
from the lowest expected value of the BLAST output
(Altschul et al. 1990).
Preparation of Aspergilli section Flavi extracts
and aflatoxin analysis
Extracts of A. flavus isolates (n = 65) were prepared and ana-
lyzed as described previously (Baranyi et al. 2015). Briefly
explained, following a microextraction procedure according
to Frisvad et al. (2007), three agar plugs (6 mm in diameter
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each) were extracted using amixture of organic solvents meth-
anol/dichloromethane/ethyl-acetate (1/2/3, v/v/v) supplement-
ed with 1% of formic acid. The extracts were ultrasonicated,
and the organic phases were separated, filtered through, and
evaporated to dryness under a slight stream of nitrogen. Dry
extracts were derivatized with trifluoroacetic acid (Fazekas
et al. 2005). HPLC (Shimadzu, Japan) equipped with a fluo-
rescence detector set at an excitation wavelength of 365 nm
and an emission wavelength of 430 nm was used for AFB1
analysis. Separations were achieved on a LiChroCART 250 ×
4 mm, 5 μm (Merck, Hungary) column coupled with a
LiChrospher 100 RP-18 (Merck, Hungary) guard column
and an injection volume of 5 μl. The isocratic mobile phase
composition was water/methanol/acetonitrile 65/17.5/17.5 (v/
v/v), and the flow rate was maintained at 1 ml/min, while the
column temperature was 40 °C. For the quantification of
AFB1, the linear calibration curve was used in a concentration
range of 6.25 to 100 ng/ml and the equation of resulted cali-
bration curve was y = 4056.2x − 7321.2 (R2 = 0.9994).
Cytotoxicity, genotoxicity, and immunomodulation
of AFB1 vs Aspergilli section Flavi extracts
Cell cultures
Human lung adenocarcinoma cells A549 and human leukemia
monocytes THP-1 (European Collection of Cell Cultures,
Salisbury, UK) were grown in 75 cm2 flasks in RPMI supple-
mented with 2 mmol/l glutamine, 10% heat-inactivated FBS,
penicillin (100 IU/ml; 1 IU 67.7 μg/ml), and streptomycin
(100 μg/ml). Cultures were maintained in a moisturized atmo-
sphere with 5% CO2 at 37 °C and 95% relative humidity.
Preparation of tested compounds
A stock solution of AFB1 (0.01 mol/l) was prepared in
DMSO/70% ethanol mixture 80/20 v/v. Weighed dried fungal
extracts were dissolved in 100% DMSO. The final concentra-
tions of AFB1 and fungal extracts as well as DMSO/ethanol
used in the treatments of cells were obtained by dilution with
the culture medium. The highest concentration of fungal
extract applied as treatment was limited by the content of
DMSO (up to 1%) that showed no significant effect on cell
viability. Mass concentrations of fungal extracts used in MTT
assay ranged from 0.05 to 0.6 mg/ml, while the corresponding
content of AFB1 in the extract of toxin-producing A. flavus
was 0.75 to 4.5 μmol/l. Concentrations of the extracts used in
other assays were selected according to the results ofMTTand
corresponded to subcytotoxic concentrations.
MTT proliferation assay
Viability of A549 cells and macrophage-like THP-1 cells was
estimated using MTT assay, as described previously (Jakšić
Despot et al. 2016). The differentiation of THP-1 cells into
macrophages was performed using PMA (20 nm/well). The
A549 (104 cells/well) and macrophage-like THP-1 cells (5 ×
104 cells/well) were grown in a 96-well flat-bottommicroplate
in RPMI 1640 medium supplemented with 10% of FBS.
Upon 24 h treatment with AFB1 (0.1 to 100 μmol/l) or with
Aspergilli extracts (0.05 to 0.6 mg/ml) of AFB1-producing
and non-producing isolates, the concentration that inhibits
growth in 50% of cells (IC50) was determined. Following
treatment, the medium was removed and 100 μl of MTT-
tetrazolium salt reagent diluted in RPMI 1640 medium with-
out FBS (0.5 mg/ml) was added (V = 100 μl per each well).
After 3 h of incubation, the medium was replaced with 100 μl
of DMSO to dissolve formazan (product of metabolised MTT
reagent), and cells were incubated at room temperature on a
rotary shaker for 15 min. The absorbance was measured using
a microplate reader (Labsystem iEMS, type 1404) at a wave-
length of 540 nm. All tests were performed in five replicates,
and results were expressed as percentage of control.
Alkaline comet assay
The extent of primary DNA damage produced after 24 h treat-
ment with AFB1 and Aspergilli extracts was assessed in A549
cells using the alkaline comet assay. A standard protocol, pro-
posed by Singh et al. (1988), with minor modifications was
used. Before treatment, A549 cells were seeded in 6-well
plates (3 × 105 cells per well) in RPMI 1640 medium
Table 1 The primers used in PCR
Primer Sequence (5′–3′) Annealing temperature (°C) Gene Reference
Cmd-5 CCGAGTACAAGGARGCCTTC 52–55 CaM Hong et al. (2005)
Cmd-6 CCGATRGAGGTCCATRACGTGG
Afl-F GGGATAGCTGTACGAGTTGTGCCAG 57–59 aflR Varga et al. (2011)
Afl-R TGGKGCCGACTCGAGGAAYGGGT
Nor-1 ACCGCTACGCCGGCACTCTCGGCA 64–66 norA Criseo et al. (2001); Varga et al. (2011)
Nor-2 GTTGGCCGCCAGCTTCGACACAGC
Omt-1 GTGGACGGACCTAGTCCGACATCAC 59–61 omtA Geisen (1996); Varga et al. (2011)
Omt-2 GTCGGCGCCACGCACTGGGTTGGGG
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supplemented with 10% of FBS. After 24 h of growth, the cell
medium was discarded and cells were treated with AFB1 (at 1
and 10 μM), Aspergilli extracts (at 0.05 and 0.1 mg/ml for
non-producing and 0.1 and 0.2 mg/ml for AFB1-producing
isolate). Control cell cultures were grown in parallel (with
and without 0.1% DMSO/ethanol) for 24 h. After 24 h of
treatment, the cells were washed with 1 ml cold PBS, scraped
with rubber, and resuspended in 300 μl of PBS. Aliquots (V =
20 μl) of this suspension were used to prepare slides for the
comet assay. Briefly, cell samples were mixed with 100 μl
0.5% LMP agarose (in Ca- andMg-free PBS) and spread onto
fully frosted slides, previously pre-coated with 1% and 0.6%
NMP agarose. The microgels were allowed to solidify on ice
for 10 min. Then, the slides were subjected to lysis at 4 °C in a
buffer containing 2.5 mol/l NaCl, 100 mmol/l Na2EDTA,
10 mmol/l Tris (pH 10), supplemented with 1% Triton-X
100. The lysis step lasted for 1 h and was followed by dena-
turation in alkaline buffer (10 mmol/l NaOH, 200 mmol/l
Na2EDTA, pH 13), for 20 min. Electrophoresis lasted for
20 min in the same buffer at 25 V and 300 mA. Microgels
were, then, neutralised with three changes of 0.4 mol/l
Tris/HCl buffer (pH 7.5), for 5 min each. The slides were kept
in a humid atmosphere in a dark box at 4 °C until further
analysis. Before image analysis, DNA was stained for
10 min with ethidium bromide (20 μg/ml). Slides were scored
using an image analysis system (Comet assay IV, Instem-
Perceptive Instruments Ltd., UK) connected to a fluorescence
microscope (Olympus, Japan). All of the experiments were
performed in duplicate, and, in each experiment, images of
200 randomly selected nucleoids (100 nucleoids from each
of the two replicate slides) were measured. Only comets with
a defined head were scored. As indicators of DNA damage,
tail length (presented in micrometres) and tail intensity (i.e.,
percentage of DNA in the comet tail) were selected (Collins
2004).
Determination of cytokine levels
To establish cytokine levels after 24 h treatment with AFB1
and Aspergilli extracts, THP-1 cells were selected as an ap-
propriate cell model. Cells were first seeded on 24-well cell
culture plates (1 × 106 cells per well) in RPMI 1640 medium
supplemented with 10% of FBS and differentiated into mac-
rophages for 24 h with addition of 40 nmol/l LM PMA for
24 h. After that, the medium was discarded, and cells were
treated with AFB1 (at 1 and 10 μmol/l LM) and Aspergilli
extracts (at 0.05 and 0.1 mg/ml for non-producing and 0.1
and 0.2 mg/ml for AFB1-producing isolate) for 24 h. Control
cell cultures were grown in parallel in RPMI 1640 medium
supplemented with 10% of FBS (with and without 0.1%
DMSO/ethanol) for 24 h. Following treatment, the cell medi-
um was harvested and frozen at − 80 °C until analysis.
Concentrations of TNF-α, IL-1β, IL-6, IL-8, and IL-17 were
determined in harvested cell medium by DuoSet ELISA kits
(R&D Systems, Minneapolis, USA) according to instructions
provided by the manufacturer and as described elsewhere
(Hulina et al. 2018). Cytokine concentrations were calculated
frommeasured optical densities determined at 450 nm, using a
microplate reader (En Vision® Multilabel Plate Reader,
Perkin Elmer) and by standard calibration curves, and results
of the three replicates were expressed as percentage of control.
Statistics
Data obtained using the MTT test, comet assay, and cytokine
concentration were first evaluated using descriptive statistics.
The results were presented as mean ± standard error of mean
(SEM). Normality of data distribution was tested by
Kolmogorov–Smirnov test; one-way ANOVA was applied
for normally distributed data (MTT test and cytokine concen-
trations) followed by Sidak’s post-test, while for non-normally
distributed data (comet assay), Kruskal–Wallis test was ap-
plied followed by Dunn’s multiple-comparison test. A value
of P < 0.05 was considered statistically significant for all cal-
culations. To obtain the IC50 from the results of the MTT
assay, non-linear dose–response fitting was applied using the
equation y = A1 + (A2 −A1) / (1 + 10^((LOGx0-x) ∗ p)).
Results and discussion
Occurrence of aflatoxigenic Aspergilli section Flavi
in air samples
The abundance of airborne Aspergillus species section Flavi
in the occupational environment (GM) in contrast to inhabited
urban homes (AP) and urban home basements (BS) as well as
outdoor air (ODA) in the six periods of sampling is presented
in Table 2. Only in GMwere these Aspergilli present through-
out the whole year, comprising 1–12% of total viable airborne
fungi, with mean absolute concentrations approximately 100
to 2000 times higher than in other indoor, as well as outdoor
locations. In the GM, the mean absolute concentrations of
Aspergilli were highest in March and September (about
2000 cfu/m3), with a maximum of 2 × 104 cfu/m3 in
September. Looking at the estimated concentrations (probable
viable number), the airborne Aspergilli section Flavi were
present at concentrations between 1.7 × 103 cfu/m3 (January)
and 1.3 × 104 cfu/m3 (March) from January to September and
dropped below 1000 cfu/m3 only in November. Comparing
the results of the present study with our previous reports, the
Aspergilli section Flavi occurred in significantly higher mean
absolute concentrations in the GM (405–2035 cfu/m3) than
both Aspergilli from the subclade Versicolores (6.5–44 cfu/
m3) and Aspergilli section Nigri (20–240 cfu/m3) (Jakšić
Despot et al. 2016; Jakšić et al. 2018). Mean concentrations
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of viable Aspergilli section Flavi were also much higher than
those reported in poultry farms, soybean and cotton mills, and
the food industry (17–137.6 cfu/m3) in India, Italy, and Egypt
(Sharma et al. 2010; Abdel Hameed et al. 2012; Cafarchia
et al. 2014). Maximum values of statistically estimated con-
centrations of Aspergilli section Flavi obtained in July (1.9 ×
105 cfu/m3) and (1.3 × 106 cfu/m3) were 10–100-fold higher
than concentrations of airborne fungi (> 104 cfu/m3) consid-
ered as a health hazard in non-sensitized subjects (Oppliger
et al. 2005). Contrary to the GM, Aspergilli section Flaviwere
rarely present or were in low concentrations (maximum
20 cfu/m3) in urban apartments and basements (AP and BS)
and outdoors which is in agreement with recently conducted
studies in homes of low-income areas in Syracuse (NY, USA)
as well as in homes of hematologic patients in Germany
(Crawford et al. 2015; Schweer et al. 2016). In most periods,
these Aspergilli comprised between 0.1 and 0.2% of total
viable airborne fungi recovered from AP, BS, and ODA.
Based onCaM gene region sequencing, among a total of 67
Aspergilli section Flavi isolates, 65 were identified as
A. flavus and 2 as A. parasiticus (Table 3) (data on
A. parasiticus are not shown; results were published in
Baranyi et al. 2015). The majority of A. flavus strains (89%)
were recovered from the GM. Among these strains, 76% pro-
duced AFB1; the highest amounts of AFB1 (10–30 μg/ml)
were produced by strains isolated in March and November.
For five strains of A. flavus, isolated from the GM environ-
ment, production of low amounts of AFB2 (0.03 ±
0.02 μg/ml) was detected, in addition to AFB1 (13.4 ±
9.8 μg/ml). These five strains represented 10% of all
A. flavus isolates from the GM environment. The production
of AFB1 and AFB2 correlated with genes detected for the
transcriptional regulator of aflatoxin biosynthesis (aflR),
norsolorinic acid reductase (norA), and O-methyltransferase
gene (omtA); 15 strains were positive for two or all three genes
for aflatoxin biosynthesis, but the amounts of the toxin were
below the LOD. Several earlier studies have suggested the
significance of respiratory exposure to A. flavus in biowaste-
handling facilities (up to 105 cfu/m3) and AFB1 in grain dust
ranging from 0.04 to 107 ng/m3 (Fischer et al. 2000a,b;
Fischer and Dott 2003). Hardin et al. (2009) reviewed the
significance of exposure to airborne fungi and mycotoxins in
light of concentration of no toxicologic concern-CoNTC
(30 ng/m3), which showed that in occupational environments,
such as grain, handling the concentration of AFB1 in the fa-
cilities can exceed the CoNTC. Recently, in poultry farms in
Portugal, A. flavus was found in three of seven poultry units,
and this Aspergilli was the third most frequently found fungal
species among indoor airborne fungi (Viegas et al. 2012). In
the same study, the presence of aflatoxigenic strains was only
confirmed in an outdoor air sample from one of the poultry
units but direct evidence of the poultry workers’ professional
exposure to AFB1 was found in 58% of positive serumT
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Table 3 AFB1-producing abilities of indoor A. flavus isolates from different sampling periods and locations
Month of collection Location Isolate IDa aflR norA omtA AFB1 (ng/ml)
January GM AF10527 I. + + + 4.9
AF10529 I. + + + 4.3
AF10523 I. + + + 4.1
AF10525 I. + + + 4.4
March GM AF10869B III. + + + < LOD
AF10873 III. + – – < LOD
AF10868A III. + + + 4.7
AF10868B III. + + + 12,000.0
AF10869A III. + + + 4.8
May GM AF10923AV. + + + 8.5
AF10926AV. + + + 5.6
AF10926B V. + + + 11.0
AF10923B V. + + + 4.6
AF10925B V. + + + 11.5
AF10927AV. + + + 4.3
AF10930B V. + – – < LOD
BS AF10959B V. + + + 5.0
July GM AF10989B VII. + + + 4.6
AF10992B VII. + + + 4.9
AF10993AVII. + + + < LOD
AF10993B VII. + + + 5.6
AF10994AVII. + + + 5.0
AF10995AVII. + + + 4.4
AF10997AVII. + + + 4.3
AF10988AVII. + + + 4.9
AF10988B VII. + + + 4.4
AF10989AVII. + + + < LOD
AF10990B VII. + + + < LOD
AF10991AVII. + + + 4.1
AF10992AVII. + + + < LOD
AF10994B VII. + + + 5.0
AF10996AVII. + + + 204.0
AF10996B VII. + + + < LOD
AF10997B VII. + + + 5.5
AF11012B VII. + + + 4.6
AP AF11008B VII. + + + < LOD
September GM AF11045A IX. + + + 15.6
AF11046A IX. + + + < LOD
AF11048B IX. + + + 4.1
AF11050A IX. + + + 4.2
AF11149B IX. – – – –
AF11046B IX. + + + < LOD
AF11047B IX. + + + < LOD
AF11049A IX. + + + 4.71
AF11049B IX. + + + 657.0
AF11050B IX. + – + 4.3
AF11051A IX. + + + 6.2
AF11053A IX. + + + 5.9
AF11054A IX. + + + 4.7
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samples (mean 2 ng/ml) in contrast to the AFB1-negative se-
rum sampled from control individuals. On the other hand, in
living environments, AFB1 does not seem to be relevant since
its formation on building materials during fungal growth has
not been detected (Rao 2016; Ren 1999). Our results suggest
that a serious threat to human health due to exposure to air-
borne A. flavus could come only in occupational environ-
ments, such as grain mill facilities, but not from exposure in
urban apartments and basements.
Cytotoxicity of AFB1 vs A. flavus extracts
The cytotoxic potential of Aspergilli extracts and AFB1 ap-
plied alone on A549 cells and THP-1 macrophage-like cells is
presented in Table 4 and Fig. 1. Although AFB1 alone signif-
icantly reduced the viability of both A549 and THP-1 macro-
phage-like cells at concentrations up to 100 μmol/l, the reduc-
tion did not fall below 50% and the IC50 was not calculated.
Our results are consistent with previous studies on A549 cells
and human bronchiolar epithelium BEAS-2B cells (Palanee
et al. 2001; Vleet et al. 2002; McKean et al. 2006). Van Veelt
et al. (2002) showed that CYP 1A2 and 3A4 enzymes are
responsible for the bioactivation of AFB1 into metabolites
(AFB1 8,9-epoxide and aflatoxin Q1) that evoked cytotoxicity
in CYP-transfected cells of the bronchiolar epithelium (B-
CMV1A2 and B3A4). On the contrary, BEAS-2B and A549
have limited CYP activity, which was in agreement with their
CYP gene expression profile (Garcia-Canton et al. 2013) and
may explain the weak cytotoxicity of AFB1 obtained in both
A549 and THP-1 macrophage-like cells.
The extract of AFB1-producing A. flavus induced a signif-
icant drop in the viability of A549 cells, while the non-
producing strain was not cytotoxic to them. THP-1 macro-
phage-like cells were more sensitive to both extracts, but the
AFB1-producing strain exerted stronger cytotoxicity with IC50
(0.37 ± 0.024 mg/ml; the corresponding AFB1 concentration
is 2.78 ± 0.18μmol/l AFB1). Thus, wemay suggest that AFB1
contributed to the A. flavus extract cytotoxicity but only in
THP-1 macrophage-like cells. Piecková and Wilkins (2004)
showed that endo- and exometabolite extracts of dust-borne
A. flavus were able to stop chicken tracheal cilia beating after
the first 24 h of activity. Recently, it was shown that exposure
Table 3 (continued)
Month of collection Location Isolate IDa aflR norA omtA AFB1 (ng/ml)
November GM AF11110A XI. + + + 11,000.0
AF11112A XI. + + + 5.0
AF11113B XI. + + + 4.5
AF11117B XI. + + + 31,000.0
AF11118A XI. + + + 4.4
AF11119A2 XI. + + + 11,000.0
AF11119B XI. + + + 5.5
AF11110B XI. + + – < LOD
AF11111B XI. + – + < LOD
AF11116A XI. + + + 5.0
AF11119A1 XI. + + + 16,000.0
BS AF11144B XI. + + + < LOD
AF11140A XI. + + + 5.9
AF11140B XI. + + + 4.7
ODA AF11146B XI. + + + 4.5
AF11148A XI. + + + 6.1
a Isolate ID, isolates ofA. flavus are deposited under their designated ID in themicrobial collection (MFBF) at theDepartment ofMicrobiology Faculty of
Pharmacy and Biochemistry, University of Zagreb
GM, grain mill; AP, apartment; BS, basement; ODA, outdoor air
Table 4 The calculated IC50 of
AFB1 negative and positive
A. flavus extracts (0.05–
0.6 mg/ml) in A549 and THP-1
macrophage-like cell lines using
non-linear curve fitting (0.9914)
Treatment IC50 (A549) IC50 (THP-1)
(x̅ ± SEM) (x̅ ± SEM)
A. flavus (AFB1-negative) > 0.6 mg/ml > 0.4 mg/ml
A. flavus (AFB1-positive) > 0.4 mg/ml 0.37 ± 0.024 mg/ml (AFB1 2.78 μM)
AFB1 > 100 μM > 100 μM
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of primary human sinonasal and bronchial cell cultures to
aflatoxins (0.1 to 10 μmol/l) as well as to conditioned media
from A. flavus reduced the ciliary beat frequency. The effect
was blocked by an anti-aflatoxin antibody suggesting that the
aflatoxin was responsible for the reduction of ciliary beat fre-
quency (Lee et al. 2016). The same study revealed that AFB2
activates protein kinase C in A549 cells, which has been
linked to inflammation and apoptosis (Diaz-Meco and
Moscat 2012; Zhao et al. 2012). Taken together, our results
suggest that although AFB1 alone exerted weak cytotoxic
properties in THP-1-like macrophages and A549 lung cells,
it significantly contributes to the cytotoxicity of A. flavus ex-
tracts. Therefore, chronic exposure to aflatoxins in the mixture
of A. flavus metabolites in an occupational environment may
stimulate epithelial damage in airways accompanied by
lowered macrophage viability contributing to the pathogene-
sis of respiratory diseases.
Genotoxicity of AFB1 vs A. flavus extracts
Genotoxic effects were evaluated in A549 cells using the al-
kaline comet assay (Fig. 2). AFB1 alone evoked significant
concentration-dependent DNA damagemeasured as tail inten-
sity but not in terms of tail length as compared to control.
Contrary to AFB1, Aspergilli extracts provoked a significant
concentration-dependent increase of tail length but not tail
intensity. The difference in the responses at DNA level ob-
served after the treatments could be explained by the intrinsic
differences in the mechanisms behind DNA lesions. Without
conducting additional experiments, we cannot establish the
exact mechanism(s) responsible for the observed effects.
However, as a comet’s tail length is proportional to the number
of relaxed DNA loops (Collins et al. 2008), it seems that
treatment with Aspergilli extracts led to an increased number
of relaxed DNA loops, but without a concomitant increase in
the amount of DNA breaks. This could be, at least in part,
associated with the chemical composition of the extract,
which—besides AFB1—contains other active compounds as
well, which possess different potentials to damage DNA or
even modulate the DNA damaging effects of AFB1 itself.
When discussing the significance of the comet assay pa-
rameters evaluated in this study, it has to be stressed that tail
intensity has been deemed the most useful because as the level
of damage increases so does the relative intensity of DNA
staining in the tail, rather than tail length (Collins et al.
2008). Therefore, the significantly increased tail intensity we
recorded at both of the tested concentrations represents an
important piece of information regarding AFB1 genotoxicity,
Fig. 1 Survival of THP-1macrophage-like cells and A549 cells after 24 h
of the treatment with the extract prepared from AFB1-negative (a) and
AFB1-positive (b) isolate of A. flavus and single AFB1 (c). Mass
concentrations of fungal extracts prepared from AFB1-negative isolate
of A. flavus were I 0.05, II 0.1, III 0.25, and IV 0.4 mg/ml (a), in the
extract of toxin-producing A. flavus I 0.1, II 0.2, III 0.4, and IV 0.6 mg/ml,
while the corresponding content of AFB1 was 0.75, 1.5, 3.0, and
4.5 μmol/l, 1–4 respectively (b). Each data point represents the mean ±
SEM of cell viability (% of control, control = 100% of cell viability). *,
**Significantly different as compared to control in A549 and THP-1
macrophage like cells, respectively (P < 0.05)
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which will be useful for planning future experiments with
other cell types and exposure scenarios.
The underlying mechanism of AFB1 genotoxicity was pre-
viously studied in the liver in vivo as well as in liver cells and
several human bronchial cell lines with good expression of
CYP 1A2 and 3A4 enzymes responsible for AFB1 biotrans-
formation into reactive AFB1 8,9-epoxide that binds to DNA
(reviewed in Marchese et al. 2018). An association between
lung cancer development following AFB1 exposure was de-
scribed in workers occupationally exposed to grain dust con-
taminated with this compound (Hayes et al. 1984). It was
demonstrated that AFB1 exposure induced the production of
a DNA binding metabolite (epoxide) by lung cytosols which
was correlated with lipoxygenase and prostaglandin H syn-
thase and increased human pulmonary susceptibility to
AFB1 (Massey et al. 2000). Also, oxidative DNA damages
in mouse lung cells were correlated to AFB1 genotoxicity,
owing to the induction of 8-hydroxy-20-deoxyguanosine (8-
OHdG) formation (Guindon et al. 2008). Although A549 cells
possess a limited expression of CYP enzymes (Garcia-Canton
et al. 2013), our results suggest that it was sufficient to induce
DNA damage upon exposure to low concentrations of AFB1.
In our previous study, AFB1 (at 5 μmol/l) also evoked signif-
icant DNA damage and mutagenic activity, as revealed by the
alkaline comet assay, and led to micronuclei formation (Jakšić
et al. 2012). Since both the AFB1-positive and the AFB1-neg-
ative Aspergilli extracts exerted similar genotoxic action in
A549 cells, wemay hypothesize that other metabolites present
in the extract might antagonise AFB1’s genotoxic action in
AFB1-producing strains.
Immunomodulatory effects of AFB1 vs A. flavus
extracts
Many macrophage and epithelial cells produce cytokines and
chemokines after challenges from various inflammatory stim-
uli. Thus, we explored the differences in the secretion of pro-
inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-8, IL-17) by
THP-1 macrophage-like cells upon exposure to single AFB1
or Aspergilli extracts (Fig. 3). TNF-α is an endogenous pyro-
gen and immunoregulatory cytokine responsible for the pro-
duction of IL-1, IL-6, and IL-8. Deficiency of TNF-α in ex-
perimental animals promoted cancer (Suganuma et al. 1999).
TNF-α stimulates polymorphonuclear leukocytes to damage
Aspergillus hyphae enhancing phagocytosis (Roilides et al.
2002). IL-1β is a potent pro-inflammatory cytokine secreted
by macrophages and monocytes which has a stimulatory ef-
fect on CD4+ T cells promoting differentiation into the T
helper cell. It has a beneficial role of mediating an immune
response against pathogenic infiltration, but it can also pro-
mote the pathogenesis of tissue damage that leads to chronic
inflammation (Eder 2009; Turner et al. 2014). Similarly to
TNF, IL-6 is a pleiotropic cytokine showing both pro-
inflammatory and anti-inflammatory activities, but, in chronic
inflammation, it is rather pro-inflammatory. The synthesis of
this cytokine is induced by IL-1 and TNF-α (Duque and
Fig. 2 Genotoxicity of AFB1-negative and AFB1-positive extracts of
A. flavus isolates as well as AFB1 applied in subcytotoxic
concentrations determined by alkaline comet assay as tail length and
tail intensity in A549 cells. C control (0.1% DMSO), I AFB1-negative
extract of A. flavus 0.05 mg/ml, II AFB1-negative extract of A. flavus
0.1 mg/ml, III AFB1-positive extract of A. flavus 0.1 mg/ml, IV AFB1-
positive extract of A. flavus 0.2 mg/ml, VAFB1 1 μmol/l, VI AFB1
10 μmol/l. The statistical significance of the treatment compared to
control is marked with an asterisk (*, P < 0.05) above each histogram
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Descoteaux 2014). IL-8, also known as chemokine CXCL8, is
a monocyte- and macrophage-derived cytokine that serves as
a chemoattractant of neutrophils to the site of infection or
injury and whose secretion from macrophages can be
stimulated with TNF-α, IL-1β, or a lipopolysaccharide
(Carré et al. 1991). IL-17 is a pro-inflammatory cytokine that
plays an essential role in the host’s defense against microbial
infections and is implicated in various inflammatory
Fig. 3 Relative concentration of cytokines measured in the supernatant of
THP-1 macrophage-like cells upon treatment: I AFB1-negative extract of
A. flavus 0.05 mg/ml, II AFB1-negative extract of A. flavus 0.1 mg/ml, III
AFB1-positive extract of A. flavus 0.1 mg/ml, IVAFB1-positive extract of
A. flavus 0.2 mg/ml, VAFB1 1 μmol/l, VI AFB1 10 μmol/l. The statistical
significance of the treatment compared to control (0.1% DMSO) is
marked with an asterisk (*, P < 0.05) above each histogram
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conditions, such as autoimmune diseases, metabolic disorders,
and cancer (Gu et al. 2013).
AFB1 alone vs Aspergilli extracts showed differences in
the immunomodulatory pattern. AFB1 has the most pro-
nounced concentration-dependent effect on IL-6 and IL-8 ex-
cretion. Although the release of TNF-α and IL-17 was also
increased by AFB1 in a concentration-dependent manner, it
was not significantly different from controls. Additionally, a
difference in IL-1β release by THP-1 macrophage-like cells
upon treatment with single AFB1 vs Aspergilli extract was
also observed; AFB1 decreased IL-1β levels, while both
Aspergilli extracts increased the release of this cytokine in a
concentration-dependent manner. Several in vivo studies have
also shown that AFB1 stimulates the expression of IL-6
(Hinton et al. 2003; Meissonnier et al. 2008; Qian et al.
2014; Abbès et al. 2016). The same in vivo studies suggested
that secretion of TNF-α significantly depends on the admin-
istered dose of AFB1; e.g., a dose of 1.8 mg/kg AFB1 during
four weeks of administration resulted in an increased expres-
sion of TNF-α (Meissonnier et al. 2008), while at a signifi-
cantly lower dose (80 μg/kg), AFB1 decreased TNF-α (Abbès
et al. 2016). In primary alveolar pig macrophages, AFB1 (1–
100 ng/ml) did not have an effect on the expression of both
TNF-α and IL-1β but decreased phagocytosis efficiency (Liu
et al. 2002). The inhibition of macrophage phagocytic activity
was also established in vivo in a study on pigs which found
that the inhalation of 16.8 μg/kg of AFB1 inhibited the phago-
cytic activity of alveolar macrophages without recovery of
function two weeks after inhalation (Jakab et al. 1994).
Similarly to our study, AFB1 evoked an increased expression
of IL-8 mRNA in human lymphoblastoid Jurkat T-cells. The
activation of an inflammatory response and over-active IL-8-
induced recruitment of neutrophils to specific tissues can re-
sult in extensive tissue damage (Luongo et al. 2014). As in our
study, IL-17 levels increased as the dose increase of AFB1 in
mice liver did, but no differences were detected between the
treated and control groups (Ishikawa et al. 2017). Opposite to
AFB1, both Aspergilli extracts provoked a significant increase
of TNF-α, IL-1β, and IL-17 in THP-1 macrophage-like cells,
while not inducing a release of IL-6 and IL-8. The excretion of
TNF-α, IL-1β, and IL-17 was probably affected by the other
metabolites in the extracts of A. flavus that could have acted in
synergy with AFB1. At the same time, the metabolite mixtures
in the extract could have had an antagonising activity on the
induction of IL-6 and IL-8. Additionally, IL-17 appeared to
play a central role in eosinophil extravasation from the blood
into the lungs of mice upon intranasal exposure to
A. fumigatus conidia (Murdock et al. 2012), which also con-
tains metabolite mixture. Taken together, AFB1 elevated IL-6
and IL-8 while Aspergilli extracts increased IL-1b, TNF-a,
and IL-17 release in THP-1 macrophage-like cells suggesting
that AFB1 alone and both AFB1-positive and AFB1-negative
Aspergilli extracts could potentially impart adverse effects on
innate immunity but with different mechanisms that could be
influenced by the metabolite mixture composition in the
extracts.
Considering the limitations of in vitro experiments, wemay
only suggest that chronic inhalatory exposure to AFB1 and/or
other A. flavus metabolites in occupational environments can
stimulate epithelial damage of airways accompanied by
lowered macrophage viability but with a different underlying
mechanism depending on the extrolite profile of the airborne
A. flavus.
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